Re-examining HSPC1 inhibitors

Abstract

HSPC1 is a critical protein in cancer development and progression, including colorectal cancer (CRC). However, clinical trial data reporting the effectiveness of HSPC1 inhibitors on several cancer types has not been as successful as predicted. Furthermore, some N-terminal inhibitors appear to be much more successful than others despite similar underlying… (More)
DOI: 10.1007/s12192-017-0774-0

Topics

8 Figures and Tables

Cite this paper

@inproceedings{Lee2017ReexaminingHI, title={Re-examining HSPC1 inhibitors}, author={Sheah Lin Lee and Nina Claire Dempsey-Hibbert and Dale Vimalachandran and Terence David Wardle and Paul Anthony Sutton and John H. Williams}, booktitle={Cell Stress and Chaperones}, year={2017} }